Globe Life Inc. (NYSE:GL) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• Globe Life Inc. has received a consensus rating of "Moderate Buy" from 11 research firms, with an average price target of $152.45.
• The company reported $3.27 EPS for the last quarter, surpassing analysts' estimates, and has set its FY 2025 guidance at 14.250-14.650 EPS.
• Globe Life has announced a quarterly dividend of $0.27 per share, which will be paid on October 31st, representing a 0.8% dividend yield.

Globe Life Inc. (NYSE:GL - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven research firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $152.4545.

A number of analysts have recently issued reports on GL shares. Wells Fargo & Company lifted their price objective on shares of Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. Truist Financial initiated coverage on shares of Globe Life in a report on Tuesday, July 15th. They issued a "buy" rating and a $150.00 price objective for the company. Morgan Stanley boosted their price objective on shares of Globe Life from $166.00 to $171.00 and gave the stock an "overweight" rating in a report on Monday, August 18th. Wall Street Zen upgraded shares of Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. Finally, Cfra Research upgraded shares of Globe Life to a "moderate buy" rating in a report on Friday, July 25th.

Globe Life Stock Performance

NYSE GL opened at $139.73 on Friday. Globe Life has a 52-week low of $99.04 and a 52-week high of $144.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.06 and a current ratio of 0.06. The company has a market capitalization of $11.32 billion, a P/E ratio of 11.17 and a beta of 0.56. The company has a fifty day moving average of $132.57 and a 200-day moving average of $126.12.

Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the firm posted $2.97 EPS. The firm's revenue was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. As a group, equities research analysts predict that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, October 3rd. Globe Life's payout ratio is presently 8.63%.

Insider Buying and Selling at Globe Life

In other news, CEO James Matthew Darden sold 33,270 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the sale, the chief executive officer directly owned 49,842 shares in the company, valued at approximately $6,758,076.78. The trade was a 40.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the sale, the chief executive officer owned 32,747 shares of the company's stock, valued at approximately $4,629,770.86. The trade was a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 84,722 shares of company stock valued at $11,733,793. Insiders own 1.51% of the company's stock.

Institutional Investors Weigh In On Globe Life

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in GL. Global Assets Advisory LLC bought a new stake in Globe Life during the 2nd quarter valued at $25,000. AdvisorNet Financial Inc raised its holdings in Globe Life by 60.0% during the 2nd quarter. AdvisorNet Financial Inc now owns 224 shares of the company's stock valued at $28,000 after buying an additional 84 shares during the last quarter. CYBER HORNET ETFs LLC bought a new stake in Globe Life during the 2nd quarter valued at $28,000. Assetmark Inc. increased its position in Globe Life by 777.8% during the 2nd quarter. Assetmark Inc. now owns 237 shares of the company's stock valued at $29,000 after purchasing an additional 210 shares during the period. Finally, MUFG Securities EMEA plc purchased a new position in Globe Life during the 2nd quarter valued at $31,000. 81.61% of the stock is currently owned by institutional investors.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.